Infectious diseases, along with cancers, are among the main causes of death among
humans worldwide. The production of therapeutic proteins for treating diseases at large …

Since its introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of
a broad spectrum of diseases and are increasingly used in nearly all branches of medicine …

Transgenic animal bioreactors can produce therapeutic proteins with high value for
pharmaceutical use. In this paper, we compared different systems capable of producing …

Milk is the primary source of nutrition for young mammals including humans. The nutritional
value of milk is mainly attributable to fats and proteins fractions. In comparison to cow milk …

Beyond the potential use of in vitro production of embryos (IVP) in breeding schemes,
embryos are also required for the establishment of new biotechnologies such as cloning and …

The interdisciplinary EC consortium (the PEGASUS project) aimed to examine the issues
raised by the development, implementation and commercialisation of genetically modified …

The scientific method demands a willingness to correct and integrate previous knowledge,
based on observable, empirical, measurable evidence and subject to laws of reasoning; yet …

Mammary gland bioreactors are promising methods for recombinant protein production.
Human neutrophil peptide 1 (HNP1) exhibits antibacterial and immune-modulating …

Proteins are considered magic molecules due to their enormous applications in the health
sector. Over the past few decades, therapeutic proteins have emerged as a promising …

Lysostaphin (LYS) is an anti-staphylococcal prokaryotic polypeptide that has been used to
avoid Staphylococcus aureus mastitis through transgenic or viral vector approaches …